Correlation Between Santen Pharmaceutical and Roche Holding

Can any of the company-specific risk be diversified away by investing in both Santen Pharmaceutical and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Santen Pharmaceutical and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Santen Pharmaceutical Co and Roche Holding Ltd, you can compare the effects of market volatilities on Santen Pharmaceutical and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Santen Pharmaceutical with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Santen Pharmaceutical and Roche Holding.

Diversification Opportunities for Santen Pharmaceutical and Roche Holding

0.33

Correlation Coefficient

Santen Pharmaceutical  Roche Holding

Weak diversification

The 3 months correlation between Santen and Roche is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Santen Pharmaceutical Co and Roche Holding Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding and Santen Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Santen Pharmaceutical Co are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding has no effect on the direction of Santen Pharmaceutical i.e., Santen Pharmaceutical and Roche Holding go up and down completely randomly.

Pair Corralation between Santen Pharmaceutical and Roche Holding

Assuming the 90 days horizon Santen Pharmaceutical Co is expected to generate 1.52 times more return on investment than Roche Holding. However, Santen Pharmaceutical is 1.52 times more volatile than Roche Holding Ltd. It trades about 0.02 of its potential returns per unit of risk. Roche Holding Ltd is currently generating about -0.03 per unit of risk. If you would invest  812.00  in Santen Pharmaceutical Co on January 29, 2024 and sell it today you would earn a total of  127.00  from holding Santen Pharmaceutical Co or generate 15.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Santen Pharmaceutical Co  vs.  Roche Holding Ltd

Santen Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Santen Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical indicators, Santen Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Roche Holding

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Roche Holding Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Santen Pharmaceutical and Roche Holding

The main advantage of trading using opposite Santen Pharmaceutical and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Santen Pharmaceutical position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.

The idea behind Santen Pharmaceutical Co and Roche Holding Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.